1 - 888 - 746 - 2107

Mon - Thurs: 9am to 8pm ET, Fri 9am to 5pm ET

Latest Newsflash

A New Approach To Stop Glaucoma

February 6, 2012

Over two million Americans suffer from glaucoma, a sight-stealing disease that has no symptoms and, once vision is lost, the loss is permanent. What many people don’t realize is that this disease is entirely preventable and there are ways to successfully battle blindness. While millions of Americans use eye drops to treat this silent sight thief, there are other treatment options that are safe, effective and can cost much less.

ABOUT GLAUCOMA

Glaucoma vision loss is caused by damage to the optic nerve, the part of the eye that carries images we see to the brain. What many people don’t realize is that this disease is entirely preventable and there are ways to successfully battle blindness. Early detection is vital to stopping the progress of the eye disease as glaucoma is naturally progressive without treatment. Today, there is no cure for glaucoma. However, there are treatment options combining medication, laser therapy and surgery that may prevent further or stop vision loss by controlling the number one risk factor of glaucoma—high levels of IOP.

ABOUT SLT

One new safe treatment option with a 93 percent success rate is called Lumenis Selective Laser Trabeculoplasty (SLT). SLT is a laser procedure used to treat glaucoma by reducing the pressure in the eye during a single, office procedure. The SLT mechanism of effect does not rely on medication. Instead, it uses an advanced laser system to target only specific cells of the eye—those containing melanin, a natural pigment. This allows for only these cells to be affected, leaving surrounding tissue intact. As a result, your body’s own healing response helps lower the pressure in your eye. It is also reimbursed by Medicare as well as other insurance providers, minimizing out-of-pocket expenses and potentially saving thousands of dollars in prescription medication costs.

Benefits of Selective Laser Trabeculoplasty (SLT):
• SLT is not associated with systemic side effects or the compliance and cost issues of medications.
• SLT utilizes selective photothermolysis to target only specific cells, leaving the surrounding tissue intact.
• SLT stimulates the body’s natural mechanisms to enhance outflow of the fluid in your eye.
Visit http://www.glaucomaslt.com for more information about this procedure.